Literature DB >> 17180536

Intraocular concentration of intravenous prednisolone in experimental autoimmune uveoretinitis mice.

Noriyasu Hashida1, Nobuyuki Ohguro2, Yukio Arakawa3, Nobuo Kurokawa3, Yasuo Tano1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17180536     DOI: 10.1007/s10384-006-0372-7

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

1.  Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody.

Authors:  K Namba; K Ogasawara; N Kitaichi; T Morohashi; Y Sasamoto; S Kotake; H Matsuda; K Iwabuchi; C Iwabuchi; S Ohno; K Onoé
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

2.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

3.  Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.

Authors:  D Avichezer; P B Silver; C C Chan; B Wiggert; R R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-01       Impact factor: 4.799

4.  Clearance of triamcinolone from vitreous.

Authors:  G N Scholes; W J O'Brien; G W Abrams; M F Kubicek
Journal:  Arch Ophthalmol       Date:  1985-10

5.  Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection.

Authors:  B M Frey; M Seeberger; F J Frey
Journal:  Transplantation       Date:  1985-03       Impact factor: 4.939

  5 in total
  1 in total

Review 1.  [Pharmacokinetics of systemic, regional and topical drugs for therapy of intraocular inflammation].

Authors:  M D Becker; S Lortz; B Flückiger; V Luginbuehl
Journal:  Ophthalmologe       Date:  2014-02       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.